Arthritis drugmakers hone pitch to consumers
May 18 2011
Makers of arthritis biologic drugs, a $15-billion market, are refining their consumer pitch to focus on prevention and early diagnosis, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.